These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 29794255)

  • 1. Comparison of four methods of establishing control limits for monitoring quality controls in infectious disease serology testing.
    Dimech W; Karakaltsas M; Vincini GA
    Clin Chem Lab Med; 2018 Oct; 56(11):1970-1978. PubMed ID: 29794255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A modified quality control protocol for infectious disease serology based on the Westgard rules.
    Wang Y; Li X; Li D; Xie Y
    Sci Rep; 2024 Jul; 14(1):16683. PubMed ID: 39030224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Six Sigma driven QC management in hepatitis C serology].
    Khelil MM
    Ann Biol Clin (Paris); 2024 Jun; 82(2):215-224. PubMed ID: 38702909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of quality control limits for serological infectious disease testing using historical data.
    Dimech W; Vincini G; Karakaltsas M
    Clin Chem Lab Med; 2015 Feb; 53(2):329-36. PubMed ID: 25153420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Counterpoint to the Letter to the Editor by Badrick and Parvin in regard to Comparison of four methods of establishing control limits for monitoring quality controls in infectious disease serology testing.
    Dimech W; Vincini G; Karakaltas M
    Clin Chem Lab Med; 2019 Apr; 57(5):e73-e74. PubMed ID: 30710479
    [No Abstract]   [Full Text] [Related]  

  • 6. The ADVIA Centaur immunoassay system--designed for infectious disease testing.
    Okrongly D
    J Clin Virol; 2004 Apr; 30 Suppl 1():S19-22. PubMed ID: 15062764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemoconcentration prior to serology testing in hemodiluted cadaver bone and tissue donors.
    LeFor WM; Shires DL; McGonigle AF; Shires DL
    Clin Transplant; 1995 Aug; 9(4):297-300. PubMed ID: 7579736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monitoring the patient response as an alternative to commercial negative quality control in infectious serology.
    Wils J; Boudewijns M; Vandermarliere M; Callewaert N
    J Clin Virol; 2015 Nov; 72():30-5. PubMed ID: 26363142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Letter to the Editor on article Dimech W, Karakaltsas M, Vincini G. Comparison of four methods of establishing control limits for monitoring quality controls in infectious disease serology testing. Clin Chem Lab Med 2018;56:1970-8.
    Badrick T; Parvin C
    Clin Chem Lab Med; 2019 Apr; 57(5):e71-e72. PubMed ID: 30904900
    [No Abstract]   [Full Text] [Related]  

  • 10. Does a change in quality control results influence the sensitivity of an anti-HCV test?
    Dimech WJ; Vincini GA; Cabuang LM; Wieringa M
    Clin Chem Lab Med; 2020 Jul; 58(8):1372-1380. PubMed ID: 32145056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Standardization and Control of Serology and Nucleic Acid Testing for Infectious Diseases.
    Dimech W
    Clin Microbiol Rev; 2021 Dec; 34(4):e0003521. PubMed ID: 34319148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statistical validation of reagent lot change in the clinical chemistry laboratory can confer insights on good clinical laboratory practice.
    Cho MC; Kim SY; Jeong TD; Lee W; Chun S; Min WK
    Ann Clin Biochem; 2014 Nov; 51(Pt 6):688-94. PubMed ID: 24497612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Time to address quality control processes applied to antibody testing for infectious diseases.
    Dimech WJ; Vincini GA; Plebani M; Lippi G; Nichols JH; Sonntag O
    Clin Chem Lab Med; 2023 Jan; 61(2):205-212. PubMed ID: 36345644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carryover: More than just a major hangover for the clinical laboratory.
    Kavsak PA; Zeidler J
    Clin Biochem; 2016 Jul; 49(10-11):735-6. PubMed ID: 27220058
    [No Abstract]   [Full Text] [Related]  

  • 15. An overview of quality control practices in Ontario with particular reference to cholesterol analysis.
    Krishnan S; Webb S; Henderson AR; Cheung CM; Nazir DJ; Richardson H
    Clin Biochem; 1999 Mar; 32(2):93-9. PubMed ID: 10211624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A model for managing quality control for a network of clinical chemistry instruments measuring the same analyte.
    Giannoli JM; Bernard M; L'Hirondel J; Heim A; Badrick T
    Clin Chem Lab Med; 2024 Apr; 62(5):853-860. PubMed ID: 37999926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Commutability limitations influence quality control results with different reagent lots.
    Miller WG; Erek A; Cunningham TD; Oladipo O; Scott MG; Johnson RE
    Clin Chem; 2011 Jan; 57(1):76-83. PubMed ID: 21097677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of quality control on accuracy in enzyme immunoassay testing for human immunodeficiency virus type 1 antibodies.
    Astles JR; Lipman HB; Schalla WO; Blumer SO; Fehd RJ; Smith C; Hearn TL
    Arch Pathol Lab Med; 1998 Aug; 122(8):700-7. PubMed ID: 9701331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the analytical performance of endocrine analytes using sigma metrics.
    Liu Y; Cao Y; Liu X; Wu L; Cai W
    J Clin Lab Anal; 2021 Jan; 35(1):e23581. PubMed ID: 32951270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response to Tony Badrick regarding "Letter to the Editor regarding the article by Wayne J. Dimech et al. Time to address quality control processes applied to antibody testing for infectious diseases. Clin Chem Lab Med 2023; 61(2):205-212 by".
    Dimech WJ; Vincini GA; Plebani M; Lippi G; Nichols JH; Sonntag O
    Clin Chem Lab Med; 2023 Jul; 61(8):e137-e139. PubMed ID: 36872632
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.